Jim Cramer Breaks Silence On DeepSeek AI Sell-Off & Discusses These 12 Stocks

8. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders In Q3 2024: 70

Bristol-Myers Squibb Company (NYSE:BMY) is a healthcare stock that has seen a lot of attention from Cramer lately. He is impressed about the firm’s schizophrenia medicine which he believes is the first of its kind in decades. This time around, amidst the DeepSeek sell-off, Cramer commented on how other sectors, such as healthcare, could offer investors refuge. He tied Bristol-Myers Squibb Company (NYSE:BMY) to a note that he had sent club members over the weekend:

“Look there is no doubt, I sent a note to people this morning, we can, from the club. Look, this is the seminal thing, you know this is going to sound like the old days, but what do you when you have these situations? You buy Bristol-Myerrrrsss! And that’s what people are going to do.”